51
Kristine Krafts, M.D. Neoplasia III (Epidemiology) and IV (Cancer Pathogenesis)

Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Kristine Krafts, M.D.

Neoplasia III (Epidemiology) and IV (Cancer Pathogenesis)

Page 2: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Neoplasia Outline

• Tumor nomenclature

• Tumor characteristics

• Epidemiology

Page 3: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Cancer Incidence

• Every year: 1.5 million new cases of cancer, >500,000 cancer deaths

• Cancer is 2nd leading cause of death (after heart disease)

• Most common cancers• Men: Prostate• Women: Breast

• Deadliest cancers• Men: Lung• Women: Lung

Page 4: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Environmental Carcinogens

• Sunlight: skin cancer

• Smoking: lung cancer

• Alcohol: liver, breast cancers

• HPV: cervical carcinoma

Page 5: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Three Types of Hereditary Cancer

• Familial cancers

• Inherited cancer syndromes

• Syndromes of defective DNA repair

Page 6: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Familial Cancers

• Most cases of cancer are “sporadic” (random)

• A small number are “familial” (related to particular germline gene mutations)

• Example: certain BRCA1 gene mutations increase risk of breast, colon, ovary, and pancreatic cancers

• Familial cancers occur earlier and are more aggressive than their sporadic counterparts

Page 7: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Inherited Cancer Syndromes

• Usually autosomal dominant

• Each has a specific gene mutation that increases risk of getting multiple cancers

• Example: Li-Fraumeni syndrome • mutation in p53 gene• 25x increased risk of getting sarcomas,

breast cancer, leukemia, and brain tumors, usually before age 50

Page 8: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Syndromes of Defective DNA Repair

• Inherited mutations in genes encoding DNA repair systems

• Greatly enhance the occurrence of mutations in other genes (“genomic instability”)

• Example: xeroderma pigmentosum• mutations in genes in “nucleotide excision

repair” pathway (fixes UV-damaged DNA• Extreme sensitivity to sun; markedly

increased risk of skin cancer (in childhood!)

Page 9: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Neoplasia Outline

• Tumor nomenclature

• Tumor characteristics

• Epidemiology

• Cancer pathogenesis

Page 10: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

What causes cancer?

Page 11: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

What causes cancer?

Non-lethal genetic damage.

Page 12: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Resistance to growth-suppressing signals

Evasion ofapoptosis

Immortality

Ability to invadeand metastasize

Alteredmetabolism

Evasion ofimmune detection

Hallmarks of Cancer

Angiogenesis

Page 13: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Hallmarks of Cancer

Page 14: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous Cell Growth

• Proto-oncogene: a normal gene whose product promotes cell growth.

• Oncogene: a mutated proto-oncogene. Causes tumor cell to grow autonomously.

• Oncoprotein: the product of an oncogene.

Page 15: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

• RAS is a signal transduction protein

• Mutated RAS is always on…

• …therefore, always transducing signals…

• …therefore, cell is always dividing.

The RAS Gene

Page 16: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million
Page 17: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million
Page 18: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Resistance to growth-suppressing signals

Hallmarks of Cancer

Page 19: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Resistance to Growth-Suppressing Signals

• Tumor suppressor gene: a normal gene whose product suppresses the cell cycle (like brakes on a car).

• Mutate these guys, and you lose the brakes!

• Must mutate both copies of the gene to cause tumors.

Page 20: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

• RB gene product stops cell at G1 checkpoint

• Mutant RB is inactive; lets cells pass through G1!

• Patients with two mutated RB genes have way, way high risk of retinoblastoma (and an increased risk of getting other tumors).

The Retinoblastoma (RB) Gene

Page 21: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million
Page 22: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

The Cell Cycle

Page 23: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Retinoblastoma

Page 24: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Resistance to growth-suppressing signals

Evasion ofapoptosis

Hallmarks of Cancer

Page 25: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Evasion of Apoptosis

• Many proteins are involved in apoptosis:• p53 • Fas (the “death receptor”)• Executioner caspases • BCL2 protein family

• If genes for these proteins are mutated, the cell will be able to avoid killing itself.

Page 26: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

• Nickname for p53: “guardian of the genome”

• If a cell’s DNA is damaged, p53 causes a pause in the cell cycle (via RB), so DNA can be repaired.

• If DNA damage is irreparable, p53 causes the cell to undergo apoptosis.

• Most human tumors have p53 mutations!

The p53 Gene

Page 27: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million
Page 28: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

p53 activated

cell cycle arrest

p53 not activated

no cell cycle arrest,no DNA repair

Page 29: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Resistance to growth-suppressing signals

Evasion ofapoptosis

Immortality

Hallmarks of Cancer

Page 30: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Immortality

• Normal cells can only undergo 60-70 doublings

• Main reason: telomere shortening!

• Stem cells and cancer cells use telomerase to maintain telomere length and keep replicating.

Page 31: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Telomeres

As cells divide over time...

Page 32: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million
Page 33: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million
Page 34: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million
Page 35: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Resistance to growth-suppressing signals

Evasion ofapoptosis

ImmortalityAngiogenesis

Hallmarks of Cancer

Page 36: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Angiogenesis

• Tumor cells need blood too!

• Can’t grow >1-2 cm without new vessels

• Tumor cells eventually learn how to stimulate angiogenesis

• Lots of cytokines involved (i.e., VEGF)

Page 37: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Tumor cells surrounding new vessel

Page 38: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Resistance to growth-suppressing signals

Evasion ofapoptosis

Immortality

Ability to invadeand metastasize

Hallmarks of Cancer

Angiogenesis

Page 39: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Ability to Invade and Metastasize

• To do this, tumor cells must:• Loosen contacts between cells• Degrade extracellular matrix• Migrate away from the original site

• Some tumors lodge in nearest capillary bed

• Some tumors show tropism

Page 40: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

clonal growth

intravasation

metastatic subclone

tumor cell embolus

extravasation

Page 41: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Tumor cells surrounding and invading vessel

Page 42: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Tumor cells now within vessel

Page 43: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Resistance to growth-suppressing signals

Evasion ofapoptosis

Immortality

Ability to invadeand metastasize

Alteredmetabolism

Evasion ofimmune detection

Hallmarks of Cancer

Angiogenesis

Page 44: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Autonomous cell proliferation

Resistance to growth-suppressing signals

Evasion ofapoptosis

Immortality

Ability to invadeand metastasize

Alteredmetabolism

Evasion ofimmune detection

Hallmarks of Cancer

Angiogenesis

Page 45: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Grading and Staging

• Used for malignant tumors• Useful for determining treatment and prognosis• Grading

• Tells you how nasty the tumor looks (use microscope)

• Somewhat useful• Staging

• Tells you how far the tumor has spread (use imaging)

• Very useful

Page 46: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Tubuleslots of tubules some tubules rare tubules

Mitoses0-9 mitoses/10 hpf 10-19 mitoses/10 hpf≥20 mitoses/10 hpf

Pleomorphismsmall, uniform cells larger, less uniform cellsmarkedly pleomorphic cells

Grading system for breast cancer

Low gradeIntermediate gradeHigh grade

123

123

123

3-56-78-9

add all points together

Grade Score 5y survival>95%80%60%

Page 47: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Low grade breast cancer

Page 48: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

High grade breast cancer

Page 49: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

T=TumorTis – in situ tumor T1 – small tumorT2 – larger tumorT3 – larger or invasive tumorT4 – very large/very invasive

N=NodesN0 – no lymph node involvement N1 – a few regional nodesN2 – lots of regional nodesN3 – distant nodes

M=MetastasesM0 – no metastases M1 – metastases

TNM staging system for non-small cell lung cancer

Page 50: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Overall stageStage 0

Stage I

Stage II

Stage III

Stage IV

TNM staging system for non-small cell lung cancer

TTis

T1 or T2

T1T2T3

T1 or T2T3

Any TT4

Any T

NN0

N0

N1N1N0

N2N1 or N2

N3Any N

Any N

MM0

M0

M0M0M0

M0M0M0M0

M1

TreatmentSurgery only

Surgery ± radiation

Surgery and radiation± chemotherapy

Chemotherapy ±radiation to debulk

Maybe surgery

Palliative careMaybe chemo or radiation

5y prognosis75%

50%

30%

10%

<2%

Page 51: Neoplasia III and IV - WordPress.com · 2019-06-24 · Neoplasia Outline • Tumor nomenclature • Tumor characteristics • Epidemiology. Cancer Incidence • Every year: 1.5 million

Grading and Staging

Grading = microscopic

Staging = clinical

Staging is more useful.